Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma cancer cells, but also increases the effectiveness of current therapies against the disease.
The research appeared September 12 in the journal Blood.
Multiple myeloma (MM) is an incurable cancer of plasma, a type of white blood cell that normally makes antibodies to fight infection. MM cells build up in the bone marrow, crowding out healthy blood-forming cells, and…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply